Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kane Biotech Inc KNBIF


Primary Symbol: V.KNE

Healthcare Biotechnology
Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired... see more

Recent & Breaking News (TSXV:KNE)

Kane Biotech Announces Closing of Loan Transaction

Marketwired June 27, 2017

Kane Biotech Inc. to Present at The MicroCap Conference on June 27th in Toronto at the Sheraton Centre Hotel

Accesswire June 12, 2017

Kane Biotech Announces Private Placement Offering

MarketWire Canada June 1, 2017

Kane Biotech - Q1 2017 Financial Reports

MarketWire Canada May 17, 2017

Kane Biotech - Business and Intellectual Property Update

MarketWire Canada May 11, 2017

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

Marketwired March 27, 2017

Kane Biotech Announces Completion of Share Consolidation

MarketWire Canada March 10, 2017

Kane Biotech Announces Exclusive License and Distribution Agreement with Dechra

Marketwired March 6, 2017

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

MarketWire Canada December 21, 2016

Kane Biotech Announces Results of Special Meeting and Proposed Share Consolidation

MarketWire Canada December 16, 2016

Kane Biotech Announces Shareholder Meeting to Consider Share Consolidation

MarketWire Canada November 25, 2016

Kane Biotech Launches New Branding for StrixNB Oral Health Products for Dogs and Cats

MarketWire Canada October 19, 2016

Kane Biotech Announces Issuance of Common Shares in Payment of Outstanding Interest

MarketWire Canada September 28, 2016

Kane Biotech Announces End of Joint Development Agreement and Appointment of Vice-President Sales

MarketWire Canada July 11, 2016

Kane Biotech Announces Closing of Private Placement Offering and Issuance of Common Shares in Payment of Outstanding Interest

MarketWire Canada June 29, 2016

Kane Biotech Announces Grant of Options

MarketWire Canada June 21, 2016

Kane Biotech Announces Board Members

MarketWire Canada June 6, 2016

Kane Biotech Announces Private Placement Offering and Proposed Consolidation of Shares

MarketWire Canada June 2, 2016

Kane Biotech Announces Insider Participation in Rights Offering

Marketwired May 4, 2016

Kane Biotech Announces bluestem(TM) Breakthrough Order with Major Retail Chain

Marketwired April 26, 2016